Clinical Trial Update: Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial studying ramucirumab with paclitaxel or FOLFIRI for advanced small intestinal adenocarcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Intestinal Adenocarcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• PACLITAXEL (PACLITAXEL)
• Ramucirumab (ramucirumab)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Metastatic Small Intestinal Adenocarcinoma, Stage III Small Intestinal Adenocarcinoma AJCC v8 | Phase 2 | Status: RECRUITING